NGF and bone cancer: It was observed that the administration of a blocking antibody to NGF significantly reduced both early- and late-stage bone cancer pain-related behaviors to a level equivalent or greater to that observed following an acute administration of 10 mg/kg or 30 mg/kg of morphine sulfate [91].